Home » First Patients Enrolled in Cordis Trial of Stent Graft System
First Patients Enrolled in Cordis Trial of Stent Graft System
Cordis Corporation, a worldwide leader in the development and manufacture
of interventional vascular technologies, announced that the first patients have been enrolled in the INNOVATION trial, which will assess the safety of
a new stent graft system, called INCRAFT, to treat abdominal aortic aneurysm.
GEN
GEN
Upcoming Events
-
07May
-
14May
-
30May